CD44: From diagnosis to therapy in the journey of oral cancer
Highlights: • Advancements in OSCC treatment have not reduced mortality due to challenges in early diagnosis, highlighting the need for prognostic biomarkers. • CSCs in OSCC fuel chemo-radio-resistance, making their targeting crucial. • CD44, a CSC biomarker, drives cancer progression and resistanc...
| 出版年: | Oral Oncology Reports |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2024-06-01
|
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2772906024003297 |